Ausschuss für Humanarzneimittel empfiehlt Zulassung von Empagliflozin in Europa
Crossref DOI link: https://doi.org/10.1007/s15006-014-2926-9
Published Online: 2014-04-16
Published Print: 2014-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Red,
Text and Data Mining valid from 2014-04-01
